CD4 dysfunction and cerebral toxoplasmosis
CD4功能障碍与脑弓形体病
基本信息
- 批准号:10403626
- 负责人:
- 金额:$ 59.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-16 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAcquired Immunodeficiency SyndromeAgonistAntigensBindingCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell MaintenanceCell physiologyCellsCentral Nervous System InfectionsCerebral ToxoplasmosisChromatinChronicCommunicable DiseasesDataDevelopmentDown-RegulationEconomicsEncephalitisEpigenetic ProcessExhibitsFailureFoodFunctional disorderGoalsHIV InfectionsHumanImmunityImmunocompromised HostIndividualInfectionLaboratoriesLifeLinkMaintenanceMalignant NeoplasmsMediatingMemoryMethylationMusOX40ParasitesPatientsPlayPopulationPredispositionPublishingReceptor GeneRecoveryReportingRoleSignal TransductionSignaling MoleculeSiteT cell responseTherapeuticTherapeutic AgentsToxoplasmaToxoplasma gondiiToxoplasmosisUnited StatesUp-Regulationchronic infectioncytotoxicexhaustionexperimental studyinsightlatent infectionmouse modelpathogenpreventprogramspromoterreactivation from latencyreceptorresponserestorationtoxoplasmic encephalitistranscription factor
项目摘要
Abstract
Latent toxoplasmosis continues to be a problem for immunocompromised infected
individuals and toxoplasmic encephalitis (TE) is one of the most common life threatening
central nervous system infections in these patients. The reactivation of latent
toxoplasmosis is attributed to lack of adequate CD4 T cell help that compromises the CD8
T cell immunity against the parasite. Similar to humans, mouse models of toxoplasmosis
have demonstrated the critical role of CD4 T cells for the maintenance of robust CD8 T
cell immunity. In a recent study we demonstrated that CD8 T dysfunction leading to
reactivation in chronically infected host is a consequence of CD4 T cell exhaustion.
Treatment of chronic host with antigen-specific non-exhausted CD4 T cells can restore
CD8 T cell functionality and prevent reactivation. Interestingly, CD4 exhaustion is linked
to up-regulation of transcription factor BLIMP-1, which causes an increase in the
expression of inhibitory receptors on these cells. Preliminary data for the proposal
suggests that during latent toxoplasmosis increased BLIMP-1 expression leads to
epigenetic changes in antigen-specific, CD4 TCM (central memory) subset. The
transcription factor gains accessibility to chromatin sites on this population and changes
their epigenetic landscape. BLIMP-1 ablation re-invigorates CD4 T cells due to
downregulation of inhibitory receptors and increased expression of positive co-stimulatory
molecules. The proposal has two specific aims. In aim 1 we will determine the chromatin
accessible sites on CD4 TCM that BLIMP-1 binds to. We plan to define the epigenetic
changes in CD4 TCM during latent toxoplasmosis that leads to their exhaustion. In aim 2
studies will be performed to evaluate if restoration of CD4 T cell function due to BLIMP-1
ablation is dependent on the up-regulation of 4-1BB and OX40 or other costimulatory
molecules identified in aim 1. We will determine if cell intrinsic signaling by these co-
stimulatory molecules is required for optimal recovery of CD4 T cell function in BLIMP-1
ablated cells. Finally, studies will be performed to determine if CD4 T cells treated with
agonist for co-stimulatory molecules downregulate inhibitory receptors on CD8 population
and confer strong effector cytotoxic program on these cells that is critical for containing
chronic toxoplasma infection.
摘要
潜伏的弓形虫病仍然是免疫功能低下的感染者的问题
个体和弓形体脑炎(TE)是最常见的威胁生命的疾病之一
这些患者的中枢神经系统感染。潜伏期的重新激活
弓形虫病归因于缺乏足够的CD4T细胞帮助而损害CD8
对寄生虫的T细胞免疫。与人类相似,弓形虫病的小鼠模型
已经证明了CD4T细胞在维持强大的CD8T细胞中的关键作用
细胞免疫。在最近的一项研究中,我们证明CD8T功能障碍会导致
慢性感染宿主的重新激活是CD4T细胞耗尽的结果。
抗原特异性未耗尽的CD4T细胞治疗慢性宿主可恢复
CD8T细胞的功能和防止重新激活。有趣的是,CD4的耗尽与
转录因子blimp-1的上调,从而导致
抑制受体在这些细胞上的表达。建议书的初步数据
提示在隐匿性弓形虫病期间,blimp-1的表达增加会导致
抗原特异的表观遗传学变化,CD4中医(中央记忆)亚集。这个
转录因子获得对该群体上染色质位点的可及性并发生变化
它们的表观遗传景观。BLIMP-1消融重新激活CD4T细胞
抑制性受体下调和正向共刺激蛋白表达增加
分子。该提案有两个具体目标。在目标1中,我们将确定染色质
气球飞艇-1绑定到的可访问的网站。我们计划定义表观遗传学
隐匿性弓形虫感染时CD4、Tcm的变化导致其衰竭。在AIM 2
将进行研究以评估CD4T细胞功能是否因BLIMP-1而恢复
消融依赖于4-1BB和OX40或其他共刺激因子的上调
目标1中确定的分子。我们将确定细胞内的信号是否通过这些共同的-
刺激分子是BLIMP-1最佳恢复CD4T细胞功能所必需的
消融的细胞。最后,将进行研究以确定CD4T细胞是否接受了
共刺激分子激动剂下调CD8细胞表面抑制性受体
并赋予这些细胞强大的效应器细胞毒程序,这对包含
慢性弓形虫感染。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Lower Dose of Infection Generates a Better Long-Term Immune Response against Toxoplasma gondii.
- DOI:10.4049/immunohorizons.2300006
- 发表时间:2023-02-01
- 期刊:
- 影响因子:0
- 作者:Moretto MM;Chen J;Meador M;Phan J;Khan IA
- 通讯作者:Khan IA
Nfkbid-mediated humoral immunity during secondary toxoplasmosis.
继发性弓形体病期间 Nfkbid 介导的体液免疫。
- DOI:10.1016/j.pt.2022.01.010
- 发表时间:2022
- 期刊:
- 影响因子:9.6
- 作者:Khan,ImtiazA;Moretto,Magali
- 通讯作者:Moretto,Magali
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IMTIAZ AHMED KHAN其他文献
Variation of Saccharoid Fraction in Diabetes Mellitus
糖尿病中类糖分数的变化
- DOI:
10.1038/215979a0 - 发表时间:
1967-08-26 - 期刊:
- 影响因子:48.500
- 作者:
IMTIAZ AHMED KHAN;M. ATAUR RAHMAN - 通讯作者:
M. ATAUR RAHMAN
IMTIAZ AHMED KHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IMTIAZ AHMED KHAN', 18)}}的其他基金
miR146a and CD4 dysfunction during chronic toxoplasmosis
慢性弓形虫病期间 miR146a 和 CD4 功能障碍
- 批准号:
9435967 - 财政年份:2018
- 资助金额:
$ 59.82万 - 项目类别:
CD8+ T Cell exhaustion during Toxoplasmosis
弓形虫病期间 CD8 T 细胞耗竭
- 批准号:
8896135 - 财政年份:2014
- 资助金额:
$ 59.82万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8329808 - 财政年份:2012
- 资助金额:
$ 59.82万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8700315 - 财政年份:2012
- 资助金额:
$ 59.82万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8892976 - 财政年份:2012
- 资助金额:
$ 59.82万 - 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
- 批准号:
8532815 - 财政年份:2012
- 资助金额:
$ 59.82万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 59.82万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 59.82万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 59.82万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 59.82万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 59.82万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 59.82万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 59.82万 - 项目类别: